Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,088 | -281,890 | -341,415 | 27,733 | 31,011 |
| Depreciation Amortization | 35,383 | 55,967 | 54,379 | 120,090 | 116,048 |
| Income taxes - deferred | N/A | N/A | N/A | 1,369 | 4,208 |
| Accounts receivable | -29,789 | -33,816 | -15,081 | 10,999 | 3,065 |
| Accounts payable and accrued liabilities | 11,035 | -226 | 7,171 | N/A | N/A |
| Other Working Capital | -33,127 | -29,067 | -7,129 | 83,470 | 73,324 |
| Other Operating Activity | 167,741 | 43,833 | 25,975 | 33,355 | 26,341 |
| Operating Cash Flow | $83,155 | $-245,199 | $-276,100 | $277,016 | $253,997 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 61,376 | 237,093 | -24,478 | -34,419 |
| PPE Investments | -16,260 | -8,444 | -22,319 | -118,153 | -237,119 |
| Other Investing Activity | 0 | 0 | 0 | 108,663 | 123,093 |
| Investing Cash Flow | $-16,260 | $52,932 | $214,774 | $-33,968 | $-148,445 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 27,865 | 199,978 | 191,310 | 1,186,537 | 705,045 |
| Debt Repayment | -106 | -157 | -180,743 | -1,349,918 | -631,875 |
| Common Stock Issued | 546,366 | 1,530 | 1,865 | 4,163 | 1,285 |
| Common Stock Repurchased | -113 | N/A | N/A | -7,946 | -34,118 |
| Dividend Paid | N/A | N/A | N/A | -17,706 | -8,829 |
| Other Financing Activity | 90,977 | -1,059 | -2,300 | -65,012 | -139,987 |
| Financing Cash Flow | $664,989 | $200,292 | $10,132 | $-249,882 | $-108,479 |
| Exchange Rate Effect | 130 | -4 | 62 | 97 | 183 |
| Beginning Cash Position | 68,028 | 60,007 | 111,139 | 73,239 | 75,983 |
| End Cash Position | 800,042 | 68,028 | 60,007 | 66,502 | 73,239 |
| Net Cash Flow | $732,014 | $8,021 | $-51,132 | $-6,737 | $-2,744 |
| Free Cash Flow | |||||
| Operating Cash Flow | 83,155 | -245,199 | -276,100 | 277,016 | 253,997 |
| Capital Expenditure | -16,260 | -8,444 | -22,319 | -219,450 | -318,811 |
| Free Cash Flow | 66,895 | -253,643 | -298,419 | 57,566 | -64,814 |